Top experts by indication
One page per indication with at least 200 key opinion leaders on file, 53 pages in all. Each ranks the experts tagged to the indication by one public measure at a time: registered trials, citations, NIH awards and congress contributions. A table is a count from a named source, not a judgment about anyone, and every row links a profile where the count can be checked. Data as of October 25, 2026.
Oncology
- Leukemia (AML/ALL/CML/CLL)1,679
- Lymphoma1,080
- Lung Cancer (NSCLC/SCLC)946
- Breast Cancer724
- Colorectal Cancer681
- Multiple Myeloma595
- Pancreatic Cancer561
- MDS / MPN545
- Sarcoma479
- Neuro-Oncology / Glioma461
- Melanoma458
- Ovarian / Gynecologic Cancer427
- Prostate Cancer412
- Gastroesophageal Cancer373
- Hepatobiliary Cancer361
- Rectal Neoplasms339
- Small Cell Lung Carcinoma338
- Head & Neck Cancer337
- Hodgkin Disease304
- Leukemia, Myeloid, Acute303
- Kidney Cancer / RCC294
- Precursor Cell Lymphoblastic Leukemia-Lymphoma277
- Carcinoma, Squamous Cell237
- Bladder / Urothelial Cancer233
Cardiology
Respiratory
Infectious Disease
Psychiatry
Neurology
Nephrology
Endocrinology/Metabolic
- Type 2 Diabetes677
- Obesity277
Ophthalmology
Rheumatology/Immunology
Gastroenterology
Dermatology
The number beside each indication is the size of its cohort, the people in the directory tagged to it. Indications under the floor are searchable in the directory but have no ranked page. Sources and methodology.